Clinical trials
Phase 3 Diabetes Mellitus trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 23 |
| AstraZeneca | 2 |
| Janssen Research & Development, LLC | 2 |
| Bayer | 1 |
| Norwegian University of Science and Technology | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 30 |
| Diabetes Mellitus, Type 2 | 22 |
| Diabetes Mellitus, Type 1 | 6 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
| Dyslipidemias | 1 |
| Erectile Dysfunction | 1 |
| Glucose Metabolism Disorders | 1 |
| Hyperlipidemias | 1 |
| Hypertension | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.